Literature DB >> 19003370

Production of high titre disabled infectious single cycle (DISC) HSV from a microcarrier culture.

T A Zecchini1, R J Smith.   

Abstract

Disabled Infectious Single Cycle (DISC) HSV-2 has been cultured in the complimentary cell line CR2 to provide high titre bulk material suitable for the purification of the virus as a live viral vaccine. CR2 cells are cultured on the microcarrier Cytodex-1 at 5 g l-1 in small scale (1 l) and larger scale (15 l) reactors. The cells are infected at an MOI of 0.01 pfu cell-1 and the culture harvested 60-72 h later. The infected cells are removed from the microcarriers by the addition of a hypotonic saline and the virus released by low-pressure disruption techniques. Virus titres achieved are compared to the standard roller bottle process. The resulting material is the starting point for the purification of the DISC-HSV virus.

Entities:  

Year:  1999        PMID: 19003370      PMCID: PMC3449936          DOI: 10.1023/A:1008005200711

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  15 in total

1.  The measurement of proliferation in tissue cultures by enumeration of cell nuclei.

Authors:  K K SANFORD; W R EARLE; V J EVANS; H K WALTZ; J E SHANNON
Journal:  J Natl Cancer Inst       Date:  1951-02       Impact factor: 13.506

2.  Production of Aujeszky vaccine by the microcarrier technology "from the ampoule to the 500 litre fermentor".

Authors:  B Baijot; M Duchene; J Stephenne
Journal:  Dev Biol Stand       Date:  1987

3.  Virus production with a newly developed microcarrier system.

Authors:  D J Giard; W G Thilly; D I Wang; D W Levine
Journal:  Appl Environ Microbiol       Date:  1977-12       Impact factor: 4.792

4.  New trends in the preparation of cell substrates for the production of virus vaccines.

Authors:  A L van Wezel
Journal:  Prog Immunobiol Stand       Date:  1971

5.  Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1.

Authors:  C S McLean; M Erturk; R Jennings; D N Challanain; A C Minson; I Duncan; M E Boursnell; S C Inglis
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

6.  A microcarrier cell culture system for large scale production of hepatitis A virus.

Authors:  A Widell; B G Hansson; E Nordenfelt
Journal:  J Virol Methods       Date:  1984-02       Impact factor: 2.014

7.  The development and use of microcarrier and glass sphere culture techniques for the production of herpes simplex viruses.

Authors:  J B Griffiths; B Thornton; I McEntee
Journal:  Dev Biol Stand       Date:  1981

8.  The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.

Authors:  B J Montagnon; B Fanget; A J Nicolas
Journal:  Dev Biol Stand       Date:  1981

9.  Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted.

Authors:  H E Farrell; C S McLean; C Harley; S Efstathiou; S Inglis; A C Minson
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

10.  Growth of a murine coronavirus in a microcarrier cell culture system.

Authors:  P J Talbot; J Lapierre; C Daniel; R Dugré; P Trépanier
Journal:  J Virol Methods       Date:  1989-07       Impact factor: 2.014

View more
  1 in total

Review 1.  Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies.

Authors:  Nathalie Clément; David R Knop; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2009-08       Impact factor: 5.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.